ArticleEuropean journal of clinical pharmacology2019

Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium.

Philippe Van Wilder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.